Clinical Trials Directory

Trials / Completed

CompletedNCT02740569

Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. Obstructive sleep apnea (OSA) may also be seen in scleroderma. Less is known regarding the prevalence of OSA in scleroderma and its association with pulmonary involvement.

Detailed description

Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. OSA may also be seen in scleroderma. Less is known regarding the prevalence of obstructive sleep apnea in scleroderma and its association with pulmonary involvement. The investigators would like to address the prevalence of OSA in patients with Scleroderma, using overnight cardiorespiratory polygraphy. Other comorbidities and pulmonary findings on computer tomography (CT) as well as lung function tests will be evaluated. The investigators plan to include 60 patients.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionObservational study. Intervention according to the clinical routines (not included in this part)

Timeline

Start date
2016-04-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-04-15
Last updated
2018-09-07

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02740569. Inclusion in this directory is not an endorsement.